Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alzheimer's diagnosis company Neuroptix gets $1.6mm in Series A

Executive Summary

Neuroptix (Alzheimer's detection devices) has raised $1.6mm through a Series A financing that was led by Launchpad Venture Group and included Maine Angels and Quan Ventures.
Deal Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Laser
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies